For Eye Care Professionals
Bausch & Lomb's Greenville, S.C. Solutions Facility Passes FDA Inspection
Bausch & Lomb Files Preliminary Proxy Statement For Merger Agreement With Warburg Pincus
Bausch & Lomb Receives Acquisition Proposal From Advanced Medical Optics For $75.00 Per Share In Cash And AMO Stock
Bausch & Lomb Names Robert J. Moore Corporate Vice President and President – U.S. Vision Care
Bausch & Lomb Introduces Ocuvite® DF Eye Vitamin Supplement for Diabetics
Bausch & Lomb Files Suit Against Alcon, Inc. for False and Misleading Advertising
Bausch & Lomb Files Remaining Outstanding Forms 10Q
Bausch & Lomb Names Joe Barr Vice President, Global R&D Vision Care
Bausch & Lomb Announces New U.S. Sales Organization Responsible for Full Retina Portfolio
Bausch & Lomb Names Efrain Rivera Senior Vice President and Chief Financial Officer, Succeeding Stephen C. McCluski Who Will Retire June 30, 2007
Bausch & Lomb Initiates Limited Voluntary Recall of Twelve Lots of ReNu MultiPlus Solution Due to Potential for Shortened Shelf Life
Bausch & Lomb Reports Preliminary and Unaudited Full-Year and Fourth-Quarter 2006 Financial Results
Bausch & Lomb Updates Status of Financial Reporting
Catherine Burzik Named to Board of Directors
Bausch & Lomb Completes Financial Restatement, Files 2005 Form 10K
Bausch & Lomb Obtains Additional Bank Waivers, Announces Consent Solicitation on Public Debt and Updates Financial Projections
Bausch & Lomb’s Retisert® Drug Implant Receives Product Specific Billing Code and Medicare Reimbursement Rate
Bausch & Lomb Announces Strategic Alliance with AcuFocus For Presbyopic Correction Technology